Abstract: A method for retro-fitting wind-energy conversion system includes disconnecting a first set of multiple windings from active circuitry; shorting together the first set of multiple windings; and connecting a second set of multiple windings to the active circuitry.

Abstract: This invention provides a nacelle of a wind energy converter and a corresponding mounting method of a nacelle of a wind energy converter and a generator for a wind energy converter. The nacelle includes a main frame; a generator including a stator and a rotor; a generator housing attached to the main frame and at least partially enclosing the stator and a rotor space; wherein the generator housing (20; 20?) has a first and second side face (S1, S2); wherein the first side face (S1) of the generator housing (20; 20?) exposes the rotor space (21); and a flange rotatably supported on the main frame and having a first end which is connected to the rotor; wherein the rotor extends into the rotor space (25) from the first side face (S1) without being supported in the generator housing.

Abstract: A compound of formula (I) and its pharmaceutically acceptable salts or solvates and physiologically hydrolysable, solubilising or immobilisable derivatives wherein: Ar is a 5-membered heteroaryl ring wherein X1 and X2 are one or two heteroatoms or Ar is a 6-membered aromatic ring, wherein heteroatoms are selected from S, O, N, Se; Z is NH, NHCO, NHSO2, N-alkyl, CH2NH, CH2N-alkyl, CH2, CH2CH2, CH?CH, CH2CONH, SO2, or SO; Y is N CR3; R1, R2, R5, R6, R7, R8 and R9 are each independently H, or a substituent; R3, when present, is selected from alkyl and a substituent, with the proviso that when Y is CR3, Ar is a 5-membered heterocycle comprising one or two N heteroatoms and Z is NH, then R3 is selected from C3+ alkyl and a substituent; R4 is selected from H, alkyl and R13 as hereinbefore defined, with the proviso that when R3 is absent, R4 is selected from alkyl and a substituent; processes for the preparation thereof, intermediates and precursors therefore and the use thereof as a medicament, and therapeutic comp

Abstract: The present invention relates to compounds of formula I, or pharmaceutically acceptable salts thereof, wherein R1 and R5 are each independently H, C(ORj?) or a hydrocarbyl group optionally substituted by one or more R6 groups; R2, R3, and R4 are each independently H, alkyl or alkenyl, each of which may be optionally substituted with one or more R7 groups; R6 and R7 are each independently halogen, NO2, CN, (CH2)mORa, O(CH2)nORb, (CH2)pNRcRd, CF3, COORe, CONRfRg, CORh, SO3H, SO2Ri, SO2NRjRk, (CH2)qNRa?CORg?, Rf?, (CH2)rNRb?SO2Rh?, SO2NRd?Ri?, SO2NRe?(CH2)sORc?, heterocycloalkyl or heteroaryl, wherein said heterocycloalkyl and heteroaryl may be optionally substituted by one or more substituents selected from aralkyl, sulfonyl, Rm and CORn; Rg?, Rh?, Ri? and Rj? are each independently selected from alkyl, aryl, aralkyl and heteroaryl, each of which may be optionally substituted with one or more substituents selected from halogen, OH, NO2, NH2 CF3 and COOH; m, p, q and r are each independently 0, 1, 2 or 3; n

Abstract: The present invention relates to substituted pyrimidines of formula I, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders and/or viral disorders.

Abstract: A plasma reactor and a method for production on wafers over a large area of monocrystalline diamond layers. The plasma reactor includes at least two flat electrodes having surfaces orientated towards each other, the electrodes being delimited respectively by an edge; a plasma region producing a plasma between the surfaces of the electrodes with an ion saturation current density of equal to or greater than 0.001 A/cm2, wherein a gas is introduced into the plasma region; and a device supplying microwaves having at least one frequency, the microwaves radiating into the plasma region and introducing a power into the plasma region contributing to the plasma production. The ion saturation current density of equal to or greater than 0.001 A/cm2 is maintained by controlling at least one of (a) a spacing between the electrodes, (b) the power of the microwaves, and (c) the frequency of the microwaves.

Abstract: The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometriosis which has a more favorable activity and side-effect profile than treatment therapies currently available. Using a mineralocorticoid receptor antagonist, it is possible to threat endometriosis permanently without any loss of bone mass.

Abstract: A metallic effect pigment comprising at least three layers: A) a layer A which comprises at least one metal MA and has an average oxygen content OA, based on the total amount of MA and OA in the layer A, B) a layer B comprising at least one metal MB and having an average oxygen content OB of 0 to 77 atom %, more particularly of 0 to 58 atom %, based on the total amount of MB and OB in the layer B, C) a layer C which comprises at least one metal MC and has an average oxygen content OC, based on the total amount of MC and OC in the layer C, the average oxygen content OAC in layers A and C being determined in accordance with the formula (I) O AC = 1 2 ? ( O A M A + O A + O C M C + O C ) ( I ) and being situated within a range from 2 to 77 atom %, more particularly from 25 to 58 atom %. The disclosure further relates to processes for preparing this effect pigment and also to its use.

Abstract: A data structure is provided for preventing access, in a computer system, to a data object having an identifier (ID). The data structure comprises a first lock object, in which the ID of the data object is stored, and in which a link to a storage location of the data object is assigned to the ID, and a second lock object, in which the ID of the data object is stored. In one embodiment, the ID is stored in the second lock object before storing the ID in the first lock object or before assigning the storage location of the data object to the ID in first lock object. Further, the ID is deleted from the second lock object after storing the ID in the first lock object or after assigning the storage location of the data object to the ID in the first lock object. The data object may be accessible by a software application, whereby the access of the software application to the data object is prevented if the ID is stored in the first or second lock object.

Abstract: The present invention provides methods and systems for controlling access to a data object having an identifier (ID). In a computer application, before access a data object, a check is performed to determine whether an ID associated with the data object is contained in a lock object and the ID is associated with a storage location. If the ID is not contained in the lock object or if the ID is not yet associated with a storage location, the data object is accessed.

Abstract: A circuit arrangement for load regulation of circuit components is arranged in a receive path of a transponder, having an input path through which a first voltage signal can be tapped, having a voltage sensor arranged in the input path for measuring the first voltage signal, having at least one output path through which a discharge current signal can be tapped, having at least one controllable auxiliary current source arranged between the input path and the output path to provide the at least one discharge current signal, the control side of the auxiliary current source being connected to an output of the voltage sensor such that the value of the discharge current signal increases exponentially with increasing voltage of the first voltage signal.

Abstract: This invention provides a nacelle of a wind energy converter and a corresponding mounting method of a nacelle of a wind energy converter and a generator for a wind energy converter. The nacelle includes a main frame; a generator including a stator and a rotor; a generator housing attached to the main frame and at least partially enclosing the stator and a rotor space; wherein the generator housing (20; 20?) has a first and second side face (S1, S2); wherein the first side face (S1) of the generator housing (20; 20?) exposes the rotor space (21); and a flange rotatably supported on the main frame and having a first end which is connected to the rotor; wherein the rotor extends into the rotor space (25) from the first side face (S1) without being supported in the generator housing.

Abstract: Methods, computer readable medium and systems are provided for moving data objects from a first storage location to a second storage location. One or more data objects may be selected having an identifier from a first storage location. The ID may be stored in a second lock object. Systems and methods consistent with the invention may determine whether the ID is stored successfully, and upon a successful storage, may store the ID in a first lock object. The data object is stored at a second storage location and the data object is deleted from the first storage location. After the ID has been stored in a first lock object, the ID is then deleted from the second lock object.

Abstract: A method comprising selecting a data object from a first storage location; assigning an identifier (ID) to the data object; storing the ID in a transactional type lock object; determining whether the ID is stored successfully in the transactional type lock object, and upon a successful storage, storing the ID in a permanent type lock object; determining whether the ID is stored successfully in the permanent type lock object, and upon a successful storage, deleting the ID from the transactional type lock object; storing the data object at the second storage location; assigning the second storage location to the ID in the permanent type lock object; deleting the data object from the first storage location; and deleting the ID from the permanent type lock object after the respective data object assigned to that ID has been deleted from the first storage location.

Abstract: An antenna is provided for a backscatter-based RFID transponder with an integrated receiving circuit, having a capacitive input impedance, for receiving a radio signal lying spectrally within an operating frequency range, whereby the antenna has two antenna arms, which extend outwardly in a spiral from a central area, in which the antenna arms can be connected to the integrated receiving circuit. According to the invention, each antenna arm has an arm length along the arm, which is selected so that one of the series resonance frequencies of the antenna is below the operating frequency range and the next higher parallel resonance frequency of the antenna is above the operating frequency range. The invention relates furthermore to a backscatter-based RFID transponder with an antenna of this type.

Abstract: Methods, computer readable medium and systems are provided for moving data objects from a first storage location to a second storage location. One or more data objects may be selected having an identifier from a first storage location. The ID may be stored in at least one transactional type lock object. Systems and methods consistent with the invention may determine whether a permanent type lock exists for a data object. If the permanent type lock does exist, systems and methods consistent with the invention may store the data object, the ID of which is contained in the at least one transactional type lock object, at the second storage location, store the ID of that data object in a permanent type lock object, assign the second storage location to the ID in the at least one permanent type lock object, and delete the ID of that data object in the transactional type lock object.

Abstract: The present invention relates to compounds of formula 1 or pharmaceutically acceptable salts thereof, wherein one of R1 and R2 is methyl, ethyl or isopropyl, and the other is H; R3 and R4 are each independently H, branched or unbranched C1-C6 alkyl, or aryl, and wherein at least one of R3 and R4 is other than H; R5 is a branched or unbranched C1-C5 alkyl group or a C1-C6 cycloalkyl group, each of which may be optionally substituted with one or more OH groups; R6, R7, R8 and R9 are each independently H, halogen, NO2, OH, OMe, CN, NH2, COOH, CONH2, or SO2NH2. A further aspect of the invention relates to pharmaceutical compositions comprising compounds of formula 1, and the use of said compounds in treating proliferative disorders, viral disorders, stroke, alopecia, CNS disorders, neurodegenerative disorders, or diabetes.

Abstract: The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts thereof. The present invention seeks to provide further substituted heteroaryl-substituted pyrimidine derivatives. More specifically, the invention relates to compounds that have broad therapeutic applications in the treatment of a number of different diseases and/or that are capable of inhibiting one or more protein kinases.

Abstract: An antenna for a backscatter-based RFID transponder is provided with an integrated receiving circuit, having a capacitive input impedance, for receiving a radio signal lying spectrally in an operating frequency range, whereby the antenna has two antenna arms, which extend outward in a spiral from a central region in which the antenna arms can be connected to the integrated receiving circuit. According to the invention, a ring-shaped trace is provided, which extends completely around the central region and is formed to connect the antenna arms conductively to one another. The invention relates further to a backscatter-based RFID transponder with an antenna of this type.

Abstract: The present invention relates to compounds of formula I or a pharmaceutically acceptable salt thereof wherein R2 is 2-hydroxymethylpyrrolidin-1-yl, or NHCH(R4)CH(R3)OH, wherein R3 is hydrogen or methyl and R4 is methyl, ethyl or isopropyl; R6 is 3-nitrophenylamino, 3,4-dimethoxybenzylamino, 3-iodobenzyl-amino, pyrid-2-yl-methylamino, pyrid-4-yl-methylamino or indan-5-amino; R9 is isopropyl or cyclopentanyl. In a further aspect, the invention relates to pharmaceutical compositions comprising said compounds, and the use thereof in treating antiproliferative disorders and or viral disorders.